Forte Biosciences, Inc. Common Stock

FBRXNASDAQ • USD
33.92 USD
↗ 2.49 (7.92%)AT CLOSE (11:59 AM EDT)
33.71
↘ 0.22 (0.63%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
33.71
↘ 0.22 (0.63%)
🔴Market: CLOSED
Open?$32.38
High?$33.95
Low?$30.95
Prev. Close?$31.43
Volume?445.4K
Avg. Volume?353.3K
VWAP?$32.45
Rel. Volume?1.26x
Bid / Ask
Bid?$13.52 × 200
Ask?$33.89 × 100
Spread?$20.37
Midpoint?$23.71
Valuation & Ratios
Market Cap?664.7M
Shares Out?13.9M
Float?10.2M
Float %?82.1%
P/E Ratio?N/A
P/B Ratio?10.90
EPS?-$3.54
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.88Strong
Quick Ratio?3.88Strong
Cash Ratio?3.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A▾
P/B?
10.90HIGH▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-8.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-113.8%WEAK▾
ROA?
-83.8%WEAK▾
Cash Flow & Enterprise
FCF?$-50998000
Enterprise Value?$587.7M
Related Companies
ARGXJBIOCLYMRLYBAUPHCALCAMGNGOSSAPLSGRIIFRXIMAIMUXIMVTZURAAPGEBRNSCABACLDXDBVT
News
Profile
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
Employees
19
Market Cap
664.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortebiorx.com
Listed
2020-06-16
Address
3060 PEGASUS PARK DRIVE
DALLAS, TX 75247
Phone: (310) 618-6994
MarketsMoversWatchlist